Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,324,842,704
-$68,640,450 QoQ
Shares Held
6,986,830
-1.1% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#31
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sanders Capital, LLC holds $1,446,627,153 across 2 Drug Manufacturers - General names. AZN ranks #1 (91.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
6,986,830 | $1,324,842,704 | |
| 2 | ABBV |
AbbVie Inc.
|
483,963 | $121,784,449 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,324,842,704 | 6,986,830 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,393,483,154 | 7,065,628 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||